Home » Topics » BioWorld Science

BioWorld Science
RSS

Blockade of DNMT1/UHRF1 complex may be an approach for NAFLD

July 6, 2022

Identification of SCUBE3 as a novel therapeutic target in HCC

July 6, 2022

New TYK2 inhibitors discovered at Jiangsu Chia Tai Tianqing Pharmaceutical Group

July 6, 2022

Beijing Tide Pharmaceutical divulges SOS1/GTPase KRAS interaction inhibitors

July 6, 2022

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent CD73 inhibitors

July 6, 2022

New EGFR inhibitors identified at PharmaBlock Sciences

July 6, 2022

Shanghai Visonpharma patents agents for treating hepatitis B virus infections

July 6, 2022

HSP60 as biomarker of chemotherapeutic response in colorectal cancer

July 6, 2022

miR-34a induction is an approach against liver metastasis

July 6, 2022

RNA-binding protein helps colon cancer cells persist

July 5, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...